Journal of Clinical Oncology
IF
32.96
Papers
117316
Papers 10000
1 page of 1,000 pages (10k results)
Newest
#8Parvesh Kumar (MU: University of Missouri)
#9Glenn J. Bubley (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 60
Last. Molly Sullivan (Cape Cod Hospital)
view all 0 authors...
Source
#1Jamie M. Sperger (UW: University of Wisconsin-Madison)H-Index: 12
#2Hamid Emamekhoo (UW: University of Wisconsin-Madison)H-Index: 8
Last. Xiao X. Wei (Harvard University)H-Index: 10
view all 0 authors...
PURPOSENearly all men with prostate cancer treated with androgen receptor (AR) signaling inhibitors (ARSIs) develop resistance via diverse mechanisms including constitutive activation of the AR pat...
Source
#1Matteo Lambertini (UniGe: University of Genoa)H-Index: 32
#2Eva Blondeaux (UniGe: University of Genoa)H-Index: 8
Last. Barbara Pistilli (Institut Gustave Roussy)H-Index: 16
view all 0 authors...
PURPOSEMany patients and physicians remain concerned about the potential detrimental effects of pregnancy after breast cancer (BC) in terms of reproductive outcomes and maternal safety. This system...
Source
#1Motoharu ShibusawaH-Index: 1
#2Keisuke Kidoguchi (Saga: Saga Group)H-Index: 1
Last. Tetsuya TanimotoH-Index: 15
view all 0 authors...
Source
#1Noura J. Choudhury (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 5
#2Jaime L. Schneider (Harvard University)H-Index: 10
Last. Alexander Drilon (Cornell University)H-Index: 57
view all 20 authors...
ABSTRACT Background ROS1 fusions are oncogenic drivers in 1-3% of non-small cell lung cancers (NSCLCs). The activity of immune checkpoint inhibitor (ICI) monotherapy or in combination with chemotherapy (chemo-ICI) in these tumors and their immunophenotype have not been systematically described. Patients and Methods In this multi-institutional retrospective study, tumor PD-L1 expression and tumor mutational burden (TMB) were assessed in patients with ROS1-rearranged NSCLC. Time to treatment disco...
Source
#1Raffaella Casolino (Glas.: University of Glasgow)H-Index: 2
#2Salvatore PaiellaH-Index: 23
Last. Fieke E.M. Froeling (Glas.: University of Glasgow)H-Index: 15
view all 0 authors...
PURPOSETo analyze the prevalence of homologous recombination deficiency (HRD) in patients with pancreatic ductal adenocarcinoma (PDAC).MATERIALS AND METHODSWe conducted a systematic review and meta...
Source
#1Shukui QinH-Index: 40
#2Feng Bi (Sichuan University)H-Index: 30
Last. Hongming Pan (ZJU: Zhejiang University)H-Index: 23
view all 0 authors...
PURPOSEDonafenib, a novel multikinase inhibitor and a deuterated sorafenib derivative, has shown efficacy in phase Ia and Ib hepatocellular carcinoma (HCC) studies. This study compared the efficacy...
Source
#1Versha Pleasant (UM: University of Michigan)H-Index: 1
#2Jennifer J. Griggs (UM: University of Michigan)H-Index: 55
Source
#1Leo Mascarenhas (SC: University of Southern California)H-Index: 24
Source
#1Andreas Kiesbye Øvlisen (AAU: Aalborg University)H-Index: 4
#2Lasse Hjort Jakobsen (AAU: Aalborg University)H-Index: 16
Last. Caroline E. Weibull (KI: Karolinska Institutet)H-Index: 14
view all 0 authors...
PURPOSEThe majority of young adults with Hodgkin lymphoma (HL) are cured, but chemotherapy-induced infertility can have profound psychosocial consequences. Providing data on parenthood rates and us...
1 CitationsSource
12345678910
Top fields of study
Cancer
Surgery
Pathology
Oncology
Physical therapy
Chemotherapy
Medicine